Arrowpoint Investment Partners (Singapore) Pte. Ltd.

Source: SEC Form 13F · as of Mar 2026

Arrowpoint Investment Partners (Singapore) Pte. Ltd. holds 46 biotech & pharma companies tracked by BioSniper, totaling $42.9M in value as of Mar 2026 (SEC Form 13F).

Companies held

46

Total value held

$42.9M

CompanySharesValue
IONSIONIS PHARMACEUTICALS INC38,988$2.9M
NBIXNEUROCRINE BIOSCIENCES INC21,556$2.8M
AXSMAxsome Therapeutics, Inc.16,401$2.8M
BMRNBIOMARIN PHARMACEUTICAL INC48,719$2.8M
PTCTPTC THERAPEUTICS, INC.39,701$2.7M
PFEPFIZER INC71,313$2.0M
REGNREGENERON PHARMACEUTICALS, INC.2,502$1.9M
JNJJOHNSON & JOHNSON7,902$1.9M
AMGNAMGEN INC4,934$1.7M
GILDGILEAD SCIENCES, INC.11,961$1.7M
VRTXVERTEX PHARMACEUTICALS INC / MA3,412$1.5M
UNHUnitedHealth Group Incorporated Common Stock (DE)5,216$1.4M
PRAXPraxis Precision Medicines, Inc.3,855$1.2M
INSMINSMED Inc7,018$1.1M
PTGXProtagonist Therapeutics, Inc9,334$984K
BLTEBELITE BIO, INC6,004$957K
MRNAModerna, Inc.17,097$869K
BIIBBIOGEN INC.4,706$863K
TEVATeva Pharmaceutical Industries Limited25,805$777K
RVMDREVOLUTION MEDICINES, INC.7,971$775K
TWSTTwist Bioscience Corp13,476$640K
MDGLMADRIGAL PHARMACEUTICALS, INC.1,192$624K
BNTXBioNTech SE6,890$612K
COGTCogent Biosciences, Inc.13,784$531K
CYTKCYTOKINETICS INC7,388$487K
GMABGenmab A/S16,030$430K
BBIOBridgeBio Pharma, Inc.5,785$430K
TNGXTango Therapeutics, Inc.20,463$428K
LLYELI LILLY & Co442$407K
ERASErasca, Inc.24,847$402K
BIOABioAge Labs, Inc.20,796$364K
APGEApogee Therapeutics, Inc.4,007$337K
IBRXImmunityBio, Inc.41,005$315K
UTHRUNITED THERAPEUTICS Corp527$313K
DYNDyne Therapeutics, Inc.17,213$312K
SYRESpyre Therapeutics, Inc.6,140$310K
TYRATyra Biosciences, Inc.8,075$309K
ALMSALUMIS INC.12,031$265K
ORKAOruka Therapeutics, Inc.5,147$252K
SMMTSummit Therapeutics Inc.12,136$230K
CGONCG Oncology, Inc.3,370$228K
NKTRNEKTAR THERAPEUTICS2,830$204K
GPCRStructure Therapeutics Inc.4,190$202K
VSTMVerastem, Inc.36,170$192K
CLYMClimb Bio, Inc.24,590$168K
IOVAIOVANCE BIOTHERAPEUTICS, INC.19,760$69K

13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.

    Arrowpoint Investment Partners (Singapore) Pte. Ltd. — Biotech 13F Holdings & Portfolio | BioSniper